ROS-responsive bionanodrug for atherosclerosis therapy via regulating glycolipid metabolism and cell crosstalk.

Jie Yu Xiao-Yan Dong Fei-Fei Yu Yi-Zhou Wu Xue Wang Hui-Ping Zhang Bin Liu Yi-Deng Jiang

Sep 2026 · Journal of Controlled Release · pp. 115362 · 0 citations

Medicine

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.